Moderna CEO Stéphane Bancel Compares COVID Shot to iPhone, Saying People Will Receive New Version Each Year

 

Moderna CEO Stéphane Bancel

The chief executive officer of Moderna, Stéphane Bancel, compared the COVID vaccine to Apple’s iPhone, stating that consumers will get a new version every year.

According to a recent interview with CNN Business, Stéphane Bancel predicted that in the near future, a yearly vaccine would be developed that would protect against multiple strains of COVID-19, the flu, and other common viruses with a single dose.

Moderna plans to release a single-dose annual booster for coronavirus, flu, and other respiratory virus within five years.

“We think we can put in a single product a lot of mRNAs, taking care of all of those viruses. And that’s once a year. You should be able to get an annual booster, a single dose, that has, in the vial, all those mRNAs for all those viruses that are, of course, adapted to the strain of a season like flu, like COVID strain, and so on,” Bencel told CNN.

Bencel compared the development of the Covid shot to the process of getting yearly upgrades on an iPhone.

“You don’t get the amazing camera, amazing everything the first time you get an iPhone, but you get a lot of things,” he said.

“A lot of us buy a new iPhone every September, and you get new apps and you get refreshed apps. And that’s exactly the same idea, which is you’ll get Covid and flu and RSV in your single dose,” he added.

A peer-reviewed study from researchers in France has concluded that both the experimental Pfizer and Moderna vaccines significantly increase the risk of myocarditis compared to the unvaccinated, as reported by The Gateway Pundit.

While both mRNA therapies were found to be linked to the life-threatening heart condition, the Moderna jabs results were particularly shocking, especially among young adults, as researchers found the risk for myocarditis diagnosis following the Moderna jab was 44 times higher risk for individuals aged 18 to 24 years old, according to the study.

According to the CDC data, the incidence of heart inflammation was 4.41 excess per 100,000 who received the Pfizer/BioNTech for males aged 18-39 versus 6.27 excess cases per 100,000 for Moderna, Reuters reported.

Om Prakash Mohapatra has been fighting for his life since January 15th due to a severe reaction from his booster shot. After thorough testing and consultation with family, doctors took Om off life support on February 4th.

According to a fundraiser page, Om was in perfect health till he received the booster shot. It started as nausea, deteriorated quickly, and turned into heart failure on the morning of Jan 15th.

Om’s sister went on social media asking for help to save his brother. Read her statement below:

Dear Indian Authorities, my brother (37 year old) is on life support in Oakville Trafalgar Memorial Hospital in Canada. He has severe brain rupture and had two cardiac arrests. Following his booster dose (Moderna) he started feeling unwell. He proactively consulted doctors, twice, and followed all prescribed medication.